Looking to publish in Cancer Immunology Immunotherapy? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginCancer Immunology, Immunotherapy provides timely open access publication of original discovery and developments in basic and translational research in the field of cancer immunology and immunotherapy. It is an online-only journal and the print ISSN 0340-7004 is ceased.
Looking to publish in Cancer Immunology Immunotherapy? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginSubmission Instructions
Cancer Immunology Immunotherapy accepts the following article types. Click on an article type to view submission instructions.
Original Research Articles
Review
Meta-Analysis Reviews
Brief Research Reports
Letter To The Editor
Clinical Trial Reports
Recent Publications
Transcription factor RBPJ improves the efficacy of PD-1/PD-L1-based therapies in non-small cell lung cancer by expanding CD8+ tissue-resident memory T cells
Gaoming Liao, Qi Liu, Min Zhang, Yan Liu, Jinwei Li, Si Huang, Jian Shi, Xionghai Qin
Dynamics of peripheral blood NKT cells and PD-L1-expressing classical monocytes as immune correlates of radiotherapy-primed atezolizumab in relapsed small cell lung cancer: a phase II study
Yang-Gun Suh, Youngjoo Lee, Sung Ho Moon, Seojin Lee, Ji-Youn Han
TREM2 blockade reprograms HER2 CAR macrophages toward inflammatory phagocytes in breast cancer models
Jassaud Marius, Ziane-Chaouche Lydia, Raffo-Romero Antonella, Salzet Michel, Duhamel Marie
Vaccination against neoantigens induced in cross-priming cDC1 in vivo
Emily S. Clark, Ana Paula Benaduce, Wasif N. Khan, Olivier Martinez, Eli Gilboa
Development of a cellular model to study CCR8 signaling in tumor-infiltrating regulatory T cells
Libao Liu, Laurie Rangan, Nathan Vanalken, Qianqian Kong, Susan Schlenner, Steven De Jonghe, Dominique Schols, Tom Van Loy
Frequently asked questions
How long does it take to publish?
Submission to first decision (median): 2 days.
Reformat to Cancer Immunology Immunotherapy using Livewrite PremiumIs a cover letter required?
A submission letter is referenced for suggesting reviewers, including institutional email addresses or other identity verification for suggested reviewers.
Reformat to Cancer Immunology Immunotherapy using Livewrite PremiumWhat are the publication costs?
Article processing charge: £2990.00 GBP / $4790.00 USD / €3590.00 EUR, plus VAT or local taxes where applicable.
Reformat to Cancer Immunology Immunotherapy using Livewrite Premium